pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Endocrinology & Metabolism · news · pharmadog
← back to Endocrinology & Metabolism
News · Endocrinology & Metabolism
432
stories
Jul 6, 26
STAT+: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms
stat
Jul 6, 26
New CDER appointment elevates longtime GLP-1 reviewer
endpoints
Jul 6, 26
Opinion: The smart way to regulate the peptide boom
stat
Jul 1, 26
Statins and blood pressure drugs changing health risks of obesity, study suggests
stat
Jul 1, 26
STAT+: The biotech scorecard for the third quarter: 15 stock-moving events to watch
stat
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 26, 26
Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda
biopharma dive
Jun 18, 26
STAT+: Cambrian’s experimental longevity drug mimics exercise
stat
Jun 16, 26
Opinion: I’m an Alzheimer’s specialist. I still missed it in my own father
stat
Jun 10, 26
Diabetes association leader apologizes for expulsion of members, pledges to rebuild trust
stat
Jun 9, 26
Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cuts
stat
Jun 8, 26
#ADA26: AstraZeneca's GLP-1 pill cuts weight by 10.5% after six months
endpoints
Jun 8, 26
When it’s time to save a limb, novel clinic meets unhoused people where they are
stat
Jun 8, 26
Opinion: American horses are obese, too
stat
Jun 7, 26
STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADA
stat
Jun 6, 26
STAT+: Triple hormone receptors, a monthly obesity drug, and a bittersweet ending
stat
Jun 5, 26
#ADA26: Roche's incretin shot works in mid-stage trial in type 1 diabetes
endpoints
Jun 5, 26
STAT+: Newer GLP-1s, pushback on research cuts, and a protest
stat
Jun 5, 26
Senior NIH official pushes MAHA strategy to skeptical ADA audience
stat
Jun 4, 26
Novo Holdings backs European fund; Alnylam sends second obesity drug into clinic
endpoints
Jun 4, 26
Male puberty is understudied — but when it starts may predict long-term health risks
stat
Jun 2, 26
Celcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trial
biopharma dive
Jun 1, 26
Servier buys into muscular dystrophy with potentially $2.7B deal
biopharma dive
May 29, 26
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
stat
May 13, 26
Hantavirus risk remains low, CDC says, citing its ‘playbook’ response
stat
May 13, 26
Dr Loghavi on the Significance of Updated WHO Diagnostic Criteria for AML in Clinical Practice
onclive
May 13, 26
FDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AML
onclive
May 13, 26
FDA Approves Sonrotoclax for Relapsed/Refractory Mantle Cell Lymphoma
onclive
May 13, 26
Dr Dinardo on the FDA Approval of Decitabine/Cedazuridine Plus Venetoclax in AML
onclive
May 13, 26
Future Directions in Metastatic Castration-Resistant Prostate Cancer
onclive
← prev
page 11 of 15
next →